Global burden of 34 cancers among women in 2020 and projections to 2040: Population-based data from 185 countries/territories.

Bizuayehu, HM; Dadi, AF; Hassen, TA; Ketema, DB; Ahmed, KY; Kassa, ZY; Amsalu, E; Kibret, GD; Alemu, AA; Alebel, A; Shifa, JE; Assefa, Y; Tessema, GA; Sarich, P; Gebremedhin, AF; Bore, MG

Global burden of 34 cancers among women in 2020 and projections to 2040: Population-based data from 185 countries/territories.

Bizuayehu, HM Dadi, AF Hassen, TA Ketema, DB Ahmed, KY Kassa, ZY Amsalu, E Kibret, GD Alemu, AA Alebel, A Shifa, JE Assefa, Y Tessema, GA Sarich, P Gebremedhin, AF Bore, MG

Permalink

Publisher:: WILEY
Publication Type:: Journal Article
Citation:: Int J Cancer, 2024, 154, (8), pp. 1377-1393
Issue Date:: 2024-04-15

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (1.65 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Bizuayehu, HM
dc.contributor.author	Dadi, AF
dc.contributor.author	Hassen, TA
dc.contributor.author	Ketema, DB
dc.contributor.author	Ahmed, KY
dc.contributor.author	Kassa, ZY
dc.contributor.author	Amsalu, E
dc.contributor.author	Kibret, GD
dc.contributor.author	Alemu, AA
dc.contributor.author	Alebel, A
dc.contributor.author	Shifa, JE
dc.contributor.author	Assefa, Y
dc.contributor.author	Tessema, GA
dc.contributor.author	Sarich, P
dc.contributor.author	Gebremedhin, AF
dc.contributor.author	Bore, MG
dc.date.accessioned	2024-09-27T04:35:02Z
dc.date.available	2023-10-25
dc.date.available	2024-09-27T04:35:02Z
dc.date.issued	2024-04-15
dc.identifier.citation	Int J Cancer, 2024, 154, (8), pp. 1377-1393
dc.identifier.issn	0020-7136
dc.identifier.issn	1097-0215
dc.identifier.uri	http://hdl.handle.net/10453/181028
dc.description.abstract	Globally women face inequality in cancer outcomes; for example, smaller improvements in life expectancy due to decreased cancer-related deaths than men (0.5 vs 0.8 years, 1981-2010). However, comprehensive global evidence on the burden of cancer among women (including by reproductive age spectrum) as well as disparities by region, remains limited. This study aimed to address these evidence gaps by considering 34 cancer types in 2020 and their projections for 2040. The cancer burden among women in 2020 was estimated using population-based data from 185 countries/territories sourced from GLOBOCAN. Mortality to Incidence Ratios (MIR), a proxy for survival, were estimated by dividing the age-standardised mortality rates by the age-standardised incidence rates. Demographic projections were performed to 2040. In 2020, there were an estimated 9.3 million cancer cases and 4.4 million cancer deaths globally. Projections showed an increase to 13.3 million (↑44%) and 7.1 million (↑60%) in 2040, respectively, with larger proportional increases in low- and middle-income countries. MIR among women was higher (poorer survival) in rare cancers and with increasing age. Countries with low Human Development Indexes (HDIs) had higher MIRs (69%) than countries with very high HDIs (30%). There was inequality in cancer incidence and mortality worldwide among women in 2020, which will further widen by 2040. Implementing cancer prevention efforts and providing basic cancer treatments by expanding universal health coverage through a human rights approach, expanding early screening opportunities and strengthening medical infrastructure are key to improving and ensuring equity in cancer control and outcomes.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	WILEY
dc.relation.ispartof	Int J Cancer
dc.relation.isbasedon	10.1002/ijc.34809
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1112 Oncology and Carcinogenesis
dc.subject.classification	Oncology & Carcinogenesis
dc.subject.classification	3211 Oncology and carcinogenesis
dc.subject.mesh	Male
dc.subject.mesh	Humans
dc.subject.mesh	Female
dc.subject.mesh	Neoplasms
dc.subject.mesh	Life Expectancy
dc.subject.mesh	Incidence
dc.subject.mesh	Forecasting
dc.subject.mesh	Global Burden of Disease
dc.subject.mesh	Global Health
dc.subject.mesh	Humans
dc.subject.mesh	Neoplasms
dc.subject.mesh	Life Expectancy
dc.subject.mesh	Incidence
dc.subject.mesh	Forecasting
dc.subject.mesh	Female
dc.subject.mesh	Male
dc.subject.mesh	Global Health
dc.subject.mesh	Global Burden of Disease
dc.subject.mesh	Male
dc.subject.mesh	Humans
dc.subject.mesh	Female
dc.subject.mesh	Neoplasms
dc.subject.mesh	Life Expectancy
dc.subject.mesh	Incidence
dc.subject.mesh	Forecasting
dc.subject.mesh	Global Burden of Disease
dc.subject.mesh	Global Health
dc.title	Global burden of 34 cancers among women in 2020 and projections to 2040: Population-based data from 185 countries/territories.
dc.type	Journal Article
utslib.citation.volume	154
utslib.location.activity	United States
utslib.for	1112 Oncology and Carcinogenesis
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
utslib.copyright.status	open_access	*
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.date.updated	2024-09-27T04:34:56Z
pubs.issue	8
pubs.publication-status	Published
pubs.volume	154
utslib.citation.issue	8

Abstract:

Globally women face inequality in cancer outcomes; for example, smaller improvements in life expectancy due to decreased cancer-related deaths than men (0.5 vs 0.8 years, 1981-2010). However, comprehensive global evidence on the burden of cancer among women (including by reproductive age spectrum) as well as disparities by region, remains limited. This study aimed to address these evidence gaps by considering 34 cancer types in 2020 and their projections for 2040. The cancer burden among women in 2020 was estimated using population-based data from 185 countries/territories sourced from GLOBOCAN. Mortality to Incidence Ratios (MIR), a proxy for survival, were estimated by dividing the age-standardised mortality rates by the age-standardised incidence rates. Demographic projections were performed to 2040. In 2020, there were an estimated 9.3 million cancer cases and 4.4 million cancer deaths globally. Projections showed an increase to 13.3 million (↑44%) and 7.1 million (↑60%) in 2040, respectively, with larger proportional increases in low- and middle-income countries. MIR among women was higher (poorer survival) in rare cancers and with increasing age. Countries with low Human Development Indexes (HDIs) had higher MIRs (69%) than countries with very high HDIs (30%). There was inequality in cancer incidence and mortality worldwide among women in 2020, which will further widen by 2040. Implementing cancer prevention efforts and providing basic cancer treatments by expanding universal health coverage through a human rights approach, expanding early screening opportunities and strengthening medical infrastructure are key to improving and ensuring equity in cancer control and outcomes.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/181028